latisse

FDA: Eyelash Thickener Claims Misleading

September 17, 2009 · Posted in Healh News · Comments Off 

Web Site for Latisse Avoids or Downplays Side Effects Associated with Product (Source: Health News: CBSNews.com)

See more here:
FDA: Eyelash Thickener Claims Misleading

bimatoprost, Latisse, Lumigan

April 30, 2009 · Posted in Healh News · Comments Off 

Title: bimatoprost, Latisse, LumiganCategory: MedicationsCreated: 5/1/2009Last Editorial Review: 5/1/2009 (Source: MedicineNet Medications General)

Original post:
bimatoprost, Latisse, Lumigan

FDA Approves Allergan’s Drug for Longer Eyelashes

December 29, 2008 · Posted in Healh News · Comments Off 

Allergan Inc, maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse. Reuters Health Information (Source: Medscape Medical News Headlines)

Read the original post:
FDA Approves Allergan’s Drug for Longer Eyelashes

FDA OKs 1st Eyelash Drug Latisse

December 28, 2008 · Posted in Healh News · Comments Off 

Title: FDA OKs 1st Eyelash Drug LatisseCategory: Health NewsCreated: 12/29/2008Last Editorial Review: 12/29/2008 (Source: MedicineNet Eyesight General) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising.

Originally posted here:
FDA OKs 1st Eyelash Drug Latisse

FDA OKs Latisse For Hypotrichosis of Eyelashes Treatment

December 27, 2008 · Posted in Healh News · Comments Off 

New prescription drug Latisse increases the length, thickness and darkness of eyelashes.

See the original post here:
FDA OKs Latisse For Hypotrichosis of Eyelashes Treatment

Allergan Gets Nod For Eyelash Treatment

December 26, 2008 · Posted in Healh News · Comments Off 

Eye care and cosmetic drug maker Allergan on Friday said its eyelash growth treatment Latisse received Food and Drug Administration approval,… (Source: Investor’s Business Daily: HEALTH)

Read more:
Allergan Gets Nod For Eyelash Treatment

FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes

December 8, 2008 · Posted in Healh News · Comments Off 

IRVINE, Calif.–(BUSINESS WIRE)–Dec 5, 2008 – Allergan, Inc. today announced the U.S.

More here:
FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes

« Previous Page